Dr Matt Glenn
CEO, Robotics Plus
Matt is an experienced Executive in the technology industry. With a PhD
on molecular biology from the University of Leeds, Matt moved to New
Zealand in 1995 for a Post Doctoral role at Genesis Research & Development Corporation. Matt became the Head of Genomics at Genesis which included, what was at the time, the largest DNA sequencing facility in the Southern Hemisphere, gaining significant experience in operations and business development. Matt was in the Leadership Team that led the IPO on the NZX and ASX in 2001, raising approximately $50m. Matt then had roles at Fonterra and Ballance (2003 – 2009), gaining expertise in strategy development; portfolio, programme, project and capability management, commercialisation of science and technology, M&A and PR and communications. Matt then spent a number of years in Management Consultancy (2009 – 2014) working in the Banking and Technology sectors. Before joining RPL, Matt was the CEO at Hill Laboratories (2014- 2018), New Zealand’s largest private analytical testing laboratory with over 400 scientists in Hamilton, Auckland, Wellington, Blenheim and Christchurch. Matt has spent significant time developing technology related business overseas particularly in Japan, US, UK and China.